Renal Transplantation and Raltegravir in HIV-Infected Patients
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the incidence of acute renal graft rejection 6 months
after transplantation in HIV-infected patients under three antiretroviral drugs regimen
including Raltegravir.
Phase:
Phase 3
Details
Lead Sponsor:
ANRS, Emerging Infectious Diseases French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)